During the past few months, President Trump and his health secretary, Robert F. Kennedy, Jr., have made sweeping, thinly ...

The GOALPOST Trial builds on the findings of CHAP and Sinkey’s preliminary clinical trial, called the ACHIEVE Trial, which is ...

About BMF-650 BMF-650 is an investigational, next-generation oral small-molecule GLP-1 RA being developed by Biomea Fusion for the treatment of obesity. Related to the broader orforglipron chemotype, ...

With the industry’s largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation ...

A new clinical trial has found that adding repeated intravenous ketamine infusions to standard care for hospitalized patients with serious depression did not provide a significant additional benefit.

AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy ...

A new analysis of more than 150 clinical trials assessed the differences in side effects from dozens of antidepressant drugs.

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

In our journey through academia, contract research organizations, big pharma and biotech startups, we have had the ...

Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, ...

Bionxt launched the final animal study needed to prepare for human testing of BNT23001, its under-the-tongue version of ...

In the world of clinical trials, patient recruitment is an ongoing challenge. | In the world of clinical trials, patient ...